180 Life Sciences to Rebrand as ETHZilla After $425M ETH Bet

180 Life Sciences to rebrand as ETHZilla and hold ETH as a treasury asset after a $425M private placement deal.

  • 180 Life Sciences to rebrand as ETHZilla
  • $425M private placement backed by major crypto firms
  • Ethereum (ETH) to be held as a treasury reserve

Nasdaq-listed biotech company 180 Life Sciences (ATNF) is making headlines by stepping far outside the lab and into the world of cryptocurrency. The firm has announced a $425 million private placement deal set to close on August 1, marking a strategic pivot towards Ethereum (ETH). Alongside the funding, the company will rebrand itself as ETHZilla, signaling a major shift in focus from medical research to crypto treasury management.

magacoinfinance

The funding round is supported by top crypto investors, including Electric Capital, Polychain Capital, and GSR. These names lend credibility to the transition and hint at serious long-term plans involving digital assets.

ETH as a Treasury Reserve: A Strategic Pivot

As part of the rebranding, ETHZilla will allocate a significant portion of the $425M toward purchasing Ethereum. This strategy mirrors what companies like MicroStrategy have done with Bitcoin—except here, the focus is squarely on ETH. The firm aims to treat Ethereum not just as an investment, but as a core treasury reserve asset.

This shift aligns with the growing institutional interest in Ethereum due to its utility in decentralized finance (DeFi), smart contracts, and upcoming scalability upgrades. ETHZilla seems to be positioning itself as a pioneer in merging traditional finance frameworks with next-gen blockchain economics.

What This Means for Crypto and Investors

The move adds momentum to the trend of traditional companies diving into crypto with serious capital. ETHZilla’s pivot could set a precedent for other mid-sized firms looking for new growth narratives. While risky, the move is backed by established crypto investors—suggesting that this isn’t just a publicity stunt, but a calculated play.

For investors, this could offer exposure to ETH through a traditional stock listing, potentially attracting institutional capital that’s still hesitant about direct crypto exposure.

Read Also :

Disclaimer: The content on CoinoMedia is for informational purposes only and does not constitute financial, investment, or legal advice. Cryptocurrency investments carry risks, and readers should conduct their own research before making any decisions. CoinoMedia is not responsible for any losses or actions taken based on the information provided.

Aurelien Sage

Aurelien Sage is a blockchain enthusiast and writer, crafting insightful articles on decentralized technologies, Web3, and the future of finance. His work simplifies complex concepts, empowering readers to navigate the evolving crypto landscape with confidence.

Related Articles

Back to top button